Literature DB >> 28368382

Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrier.

A Garnier1, T Guillaume1, P Peterlin1, M C Béné2, Y Le Bris2, V Dubruille1, B Mahé1, T Gastinne1, C Touzeau1, N Blin1, S Le Gouill1, P Moreau1, P Chevallier1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28368382     DOI： 10.1038/bmt.2017.60

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  6 in total

1.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; David H Sachs; Megan Sykes; A Benedict Cosimi
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

Review 2.  Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation.

Authors:  Leo Luznik; Paul V O'Donnell; Ephraim J Fuchs
Journal:  Semin Oncol       Date:  2012-12       Impact factor: 4.929

3.  HLA-haploidentical hematopoietic SCT from collateral related donors without in vitro T-cell depletion for hematological malignancies.

Authors:  Y-y Zhang; D-h Liu; K-y Liu; L-p Xu; H Chen; W Han; Y Wang; X-j Huang
Journal:  Bone Marrow Transplant       Date:  2014-02-10       Impact factor: 5.483

Review 4.  How to select the best available related or unrelated donor of hematopoietic stem cells?

Authors:  Jean-Marie Tiercy
Journal:  Haematologica       Date:  2016-05-31       Impact factor: 9.941

5.  Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide.

Authors:  Ashley Munchel; Chimen Kesserwan; Heather J Symons; Leo Luznik; Yvette L Kasamon; Richard J Jones; Ephraim J Fuchs
Journal:  Pediatr Rep       Date:  2011-06-22

Review 6.  How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?

Authors:  Ying-Jun Chang; Leo Luznik; Ephraim J Fuchs; Xiao-Jun Huang
Journal:  J Hematol Oncol       Date:  2016-04-12       Impact factor: 17.388
  6 in total
  1 in total

Review 1.  HLA-Haploidentical Family Donors: The New Promise for Childhood Acute Lymphoblastic Leukaemia?

Authors:  Syaza Ab Rahman; Toni Matic; Maya Yordanova; Hany Ariffin
Journal:  Front Pediatr       Date:  2022-01-21       Impact factor: 3.418
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.